Michael D. Barker

2.3k total citations
44 papers, 1.1k citations indexed

About

Michael D. Barker is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Michael D. Barker has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Oncology. Recurrent topics in Michael D. Barker's work include Complement system in diseases (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Protease and Inhibitor Mechanisms (7 papers). Michael D. Barker is often cited by papers focused on Complement system in diseases (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Protease and Inhibitor Mechanisms (7 papers). Michael D. Barker collaborates with scholars based in United Kingdom, Saudi Arabia and United States. Michael D. Barker's co-authors include Norman McKie, Kevin Langton, Anthony P. Hollander, Wael Kafienah, James E. Pease, Heather F. Bigg, Andrew D. Rowan, Tim E. Cawston, Iván Martín and Olivier Démarteau and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Chemical Communications.

In The Last Decade

Michael D. Barker

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Barker United Kingdom 19 391 232 221 180 164 44 1.1k
J. Mollenhauer Germany 16 344 0.9× 346 1.5× 158 0.7× 57 0.3× 103 0.6× 28 1.1k
Audrey M. Bernstein United States 20 504 1.3× 51 0.2× 152 0.7× 133 0.7× 184 1.1× 42 1.3k
Norman McKie United Kingdom 22 632 1.6× 171 0.7× 349 1.6× 109 0.6× 156 1.0× 33 1.3k
Gudrun Bäckström Sweden 14 1.3k 3.2× 69 0.3× 333 1.5× 119 0.7× 100 0.6× 18 2.1k
Lior Zilberberg United States 20 824 2.1× 134 0.6× 275 1.2× 93 0.5× 51 0.3× 24 1.7k
Emanuela Moroni Italy 16 1.4k 3.5× 85 0.4× 331 1.5× 362 2.0× 63 0.4× 20 2.1k
Yoshihiko Yamada United States 14 1.1k 2.8× 155 0.7× 396 1.8× 180 1.0× 162 1.0× 15 2.2k
Richard J. Bauer Germany 22 727 1.9× 73 0.3× 199 0.9× 202 1.1× 91 0.6× 55 1.6k
Juan Saus Spain 22 754 1.9× 122 0.5× 385 1.7× 205 1.1× 198 1.2× 40 1.9k
Kerstin Tiedemann Canada 23 810 2.1× 147 0.6× 460 2.1× 77 0.4× 58 0.4× 41 1.8k

Countries citing papers authored by Michael D. Barker

Since Specialization
Citations

This map shows the geographic impact of Michael D. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Barker more than expected).

Fields of papers citing papers by Michael D. Barker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Barker. The network helps show where Michael D. Barker may publish in the future.

Co-authorship network of co-authors of Michael D. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Barker. A scholar is included among the top collaborators of Michael D. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Barker. Michael D. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grant, Emma K., Sophie M. Bertrand, Kenneth Down, et al.. (2023). Covalent targeting of non-cysteine residues in PI4KIIIβ. RSC Chemical Biology. 4(12). 1111–1122. 3 indexed citations
2.
Down, Kenneth, et al.. (2020). Investigating the effects of the core nitrogen atom configuration on the thermodynamic solubility of 6,5-bicyclic heterocycles. Bioorganic & Medicinal Chemistry Letters. 33. 127752–127752. 7 indexed citations
3.
Barker, Michael D., John Liddle, Francis Atkinson, et al.. (2018). Discovery of potent and selective Spleen Tyrosine Kinase inhibitors for the topical treatment of inflammatory skin disease. Bioorganic & Medicinal Chemistry Letters. 28(21). 3458–3462. 18 indexed citations
4.
Chen, Yung‐Yi, Nicola J. Brown, Claire E. Lewis, et al.. (2013). A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice. Angiogenesis. 17(1). 207–219. 22 indexed citations
5.
Crawford, Aileen, et al.. (2010). Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture. Journal of Tissue Engineering and Regenerative Medicine. 4(8). 611–618. 8 indexed citations
6.
Crawford, Aileen, et al.. (2010). Genetic Modification of Chondrocytes Using Viral Vectors. Methods in molecular biology. 695. 99–114. 1 indexed citations
7.
Woodrow, Michael D., Stuart P. Ballantine, Michael D. Barker, et al.. (2009). Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration. Bioorganic & Medicinal Chemistry Letters. 19(5). 1380–1385. 54 indexed citations
8.
Barker, Michael D., et al.. (2006). Cyclical variation of serum neutral endopeptidase lost in asthmatics: A pilot study. Pathophysiology. 14(1). 29–33. 2 indexed citations
9.
10.
11.
Bevitt, Debra J., Zheng Li, Christine E. Arris, et al.. (2003). Expression of ADAMTS metalloproteinases in the retinal pigment epithelium derived cell line ARPE-19: transcriptional regulation by TNFα. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1626(1-3). 83–91. 44 indexed citations
12.
Arris, Christine E., Debra J. Bevitt, Zheng Li, et al.. (2003). Expression of mutant and wild-type TIMP3 in primary gingival fibroblasts from Sorsby's fundus dystrophy patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1638(1). 20–28. 20 indexed citations
13.
Pease, James E., et al.. (2002). Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression. European Journal of Immunology. 32(4). 1052–1058. 31 indexed citations
14.
Langton, Kevin, Michael D. Barker, & Norman McKie. (1998). Localization of the Functional Domains of Human Tissue Inhibitor of Metalloproteinases-3 and the Effects of a Sorsby's Fundus Dystrophy Mutation. Journal of Biological Chemistry. 273(27). 16778–16781. 111 indexed citations
15.
Scicinski, Jan, Michael D. Barker, Peter Murray, & Emma M. Jarvie. (1998). The solid phase synthesis of a series of tri-substituted hydantoin ligands for the somatostatin SST5 receptor. Bioorganic & Medicinal Chemistry Letters. 8(24). 3609–3614. 26 indexed citations
16.
Monk, Peter N., Michael D. Barker, Linda Partridge, & James E. Pease. (1995). Mutation of Glutamate 199 of the Human C5a Receptor Defines a Binding Site for Ligand Distinct from the Receptor N Terminus. Journal of Biological Chemistry. 270(28). 16625–16629. 32 indexed citations
17.
Monk, Peter N., Michael D. Barker, & Linda Partridge. (1994). Multiple signalling pathways in the C5a-induced expression of adhesion receptor Mac-1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1221(3). 323–329. 9 indexed citations
18.
Monk, Peter N., et al.. (1994). Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells. European Journal of Immunology. 24(11). 2922–2925. 14 indexed citations
19.
Pease, James E., Dennis R. Burton, & Michael D. Barker. (1993). The generation of stable CHO cell lines expressing very high levels of complement C5A receptors and subsequent modulation of binding affinity for C5A.. PubMed. 29(2). 339–47. 4 indexed citations
20.
Hoshino, Tomoyuki, et al.. (1971). 27. Glioma : Its Biology in vivo and in vitro. Neurologia medico-chirurgica. 11. 125–127. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Mollenhauer Breakdown of academic impact, for papers by Audrey M. Bernstein Breakdown of academic impact, for papers by Norman McKie Breakdown of academic impact, for papers by Gudrun Bäckström Breakdown of academic impact, for papers by Lior Zilberberg Breakdown of academic impact, for papers by Emanuela Moroni Breakdown of academic impact, for papers by Yoshihiko Yamada Breakdown of academic impact, for papers by Richard J. Bauer Breakdown of academic impact, for papers by Juan Saus Breakdown of academic impact, for papers by Kerstin Tiedemann
Rankless by CCL
2026